Background A better understanding of motivations to participate as well as
recommendations to reduce barriers to enrollment may assist in design of future clinical …

Abstract Background/Aims Clinical trial recruitment is often the rate-limiting step in the
development of new treatments reaching patients across all disease states. With many …

Background Clinical trial recruitment is often the rate-limiting step in the development of new
treatments reaching patients across all disease states. With more than 1500 currently …

Background The rising incidence and prevalence of inflammatory bowel disease (IBD), its
uncertain aetiology and multidimensional and negative effects on people's lives have …

Background Despite recent progress, inflammatory bowel disease (IBD) therapies with
pronounced long-term efficacy and improved safety are needed. IBD clinical trials face …

Background Despite a sizeable inflammatory bowel disease (IBD) population in the United
States, large trials in IBD have difficulty recruiting patients. Reasons for low enrollment are …

Background Clinical trial recruitment is the rate-limiting step in developing new treatments.
To understand inflammatory bowel disease (IBD) patient recruitment, we investigated two …

Background: Clinical trials are designed to investigate innovative diagnostic and therapeutic
strategies for patients. However, factors that influence patients with inflammatory bowel …

Abstract Background and Aims There are currently several recruitment challenges in
randomized controlled trials (RCTs) for inflammatory bowel disease (IBD), which prolong the …

Background: Clinical therapeutic trials are a fundamental tool for identifying and testing new
categories of drugs useful for ensuring clinical benefit in patients with Inflammatory Bowel …